XML 46 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (Unaudited) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2013
Dec. 31, 2012
ASSETS:    
Cash and cash equivalents $ 291,793 $ 463,388
Short-term investments 270,027 457,685
Accounts Receivable, Net 383,471 398,739
Inventories:    
Raw materials 105,246 93,009
Work in process 132,111 124,737
Finished goods 286,146 237,374
Total inventories 523,503 455,120
Prepaid Expenses 131,357 92,489
Other current assets 74,392 69,261
Total current assets 1,674,543 1,936,682
Property, plant and equipment, at cost 1,065,684 1,012,034
Less: accumulated depreciation and amortization (640,608) (595,096)
Property, plant and equipment, net 425,076 416,938
Goodwill, net 513,705 495,418
Purchased intangibles, net 276,054 260,939
Other investments 354,733 293,613
Other assets 36,297 39,913
Total assets 3,280,408 3,443,503
LIABILITIES AND STOCKHOLDERS' EQUITY:    
Accounts payable 131,899 130,867
Accrued payroll and employee benefits 133,218 135,955
Notes payable and current maturities of long-term debt 1,705 1,750
Income and other taxes payable 32,424 34,779
Accrued royalties 19,860 29,718
Other current liabilities 143,779 139,331
Total current liabilities 462,885 472,400
Long-term debt, net of current maturities 435,541 732,414
Other long-term liabilities 257,742 223,149
Total liabilities 1,156,168 1,427,963
Bio-Rad stockholders' equity:    
Additional paid-in capital 232,031 212,244
Retained earnings 1,575,981 1,528,327
Accumulated other comprehensive income 316,326 274,532
Total Bio-Rad stockholders' equity 2,124,240 2,015,005
Noncontrolling interests 0 535
Total stockholders' equity 2,124,240 2,015,540
Total liabilities and stockholders' equity 3,280,408 3,443,503
Common Class A [Member]
   
Bio-Rad stockholders' equity:    
Common stock 2 2
Common Class B [Member]
   
Bio-Rad stockholders' equity:    
Common stock 1 1
Treasury Class A [Member]
   
Bio-Rad stockholders' equity:    
Treasury Stock, Value (12) (12)
Treasury Class B [Member]
   
Bio-Rad stockholders' equity:    
Treasury Stock, Value $ (89) $ (89)